Cargando…
Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina
OBJECTIVE: To describe clinical effectiveness of belimumab for systemic lupus erythematosus (SLE) in real-world practice in Argentina. METHODS: This retrospective, observational study analysed medical record data of patients with SLE treated with belimumab in 15 centres in Argentina. Primary endpoin...
Autores principales: | Babini, A, Cappuccio, A M, Caprarulo, C, Casado, G, Eimon, A, Figueredo, H, García, M A, Magri, S, Mannucci, P, Perez Rodriguez, S, Pons-Estel, B A, Velozo, E J, Iglesias-Rodriguez, M, Streger, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536527/ https://www.ncbi.nlm.nih.gov/pubmed/32791930 http://dx.doi.org/10.1177/0961203320947814 |
Ejemplares similares
-
Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015) -
Belimumab in Systemic Lupus Erythematosus
por: Srivastava, Ankita
Publicado: (2016) -
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
por: Urowitz, Murray B., et al.
Publicado: (2022) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022) -
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
por: Dimelow, Richard, et al.
Publicado: (2020)